Search results
1,533 Shares in AbbVie Inc. (NYSE:ABBV) Acquired by Warren Street Wealth Advisors LLC
ETF DAILY NEWS· 4 days agoWarren Street Wealth Advisors LLC acquired a new position in AbbVie Inc. (NYSE:ABBV – Free Report) in the fourth quarter, according to its most recent 13F filing with the ...
AbbVie Inc. (NYSE:ABBV) Shares Bought by First Financial Bank Trust Division
ETF DAILY NEWS· 3 days agoFirst Financial Bank Trust Division boosted its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 967.2% during the 1st quarter, according to the company in its ...
General Partner Inc. Buys 1,792 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 3 days agoGeneral Partner Inc. boosted its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 716.8% in the first quarter, according to its most recent disclosure with the Securities ...
Park National Corp OH Has $24.48 Million Holdings in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 3 days agoPark National Corp OH reduced its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 7.4% during the first quarter, according to the company in its most recent filing with ...
Modus Advisors LLC Acquires 450 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 3 days agoModus Advisors LLC raised its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 2.0% in the 1st quarter, according to the company in its most recent Form 13F ...
As AbbVie Drug Gets FDA Nod, Traders Can Look Up to These Targets
TheStreet.com· 2 days agoAbbVie (ABBV) on Wednesday won Food and Drug Administration approval for a new use for its drug...
AbbVie stock price forecast: $200 on the cards? | Invezz
Invezz· 2 days agoOn June 20, 2024, AbbVie Inc. (NYSE:ABBV) announced that it has received FDA approval for expanding the use of its interleukin-23 (IL-23) inhibitor, Skyrizi, to treat adults ...
Canandaigua National Bank & Trust Co. Trims Holdings in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 3 days agoCanandaigua National Bank & Trust Co. reduced its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 3.1% in the 1st quarter, according to the company in its most ...
AbbVie (ABBV) Exceeds Market Returns: Some Facts to Consider
Zacks· 4 days agoFree Report) ending at $171.36, denoting a +0.99% adjustment from its last day's close. This change outpaced the S&P 500's 0.25% gain on the day. In that same time, the Medical sector gained ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Vanguard Group Inc.
ETF DAILY NEWS· 4 days agoVanguard Group Inc. trimmed its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 0.2% during the 4th quarter, according to its most recent filing with the Securities and ...